## Abstract Hepatocellular carcinoma (HCC) is one of the most common cancers worldโwide but the molecular mechanisms that underlie hepatocarcinogenesis are not fully determined. On the same surgical sample with HCC, we performed microarrayโbased gene expression profiling and karyotype analysis usin
IGFBP7 downregulation is associated with tumor progression and clinical outcome in hepatocellular carcinoma
โ Scribed by Yoshito Tomimaru; Hidetoshi Eguchi; Hiroshi Wada; Shogo Kobayashi; Shigeru Marubashi; Masahiro Tanemura; Koji Umeshita; Tonsok Kim; Kenichi Wakasa; Yuichiro Doki; Masaki Mori; Hiroaki Nagano
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- French
- Weight
- 768 KB
- Volume
- 130
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Insulinโlike growth factorโbinding protein 7 (IGFBP7) functions in several cellular processes including proliferation, senescence and apoptosis. This study analyzed IGFBP7 function in hepatocellular carcinoma (HCC) cells by gene manipulation and investigated the prognostic significance of IGFBP7 expression in clinical HCC samples. In this study, we investigated changes in malignant potential such as cell growth and invasiveness in an HCC cell line, PLC/PRF/5, after transfection with shRNA against IGFBP7. The extent of apoptosis and cell cycle progression were examined after the transfection. The correlation between immunohistochemically determined IGFBP7 expression and longโterm postoperative prognosis after curative resection was also investigated in clinical HCC specimens obtained from 104 patients. PLC/PRF/5 cells transfected with shRNA against IGFBP7 showed significantly more rapid growth and stronger invasiveness than control cells. Annexin V assays showed that the IGFBP7โdepleted cells were significantly more resistant to apoptosis than the control cells, and showed decreased expression of cleaved caspaseโ3 and PARP. Cell cycle progression was more rapid in the IGFBP7โsuppressed cells. In clinical HCC specimens, IGFBP7 expression was judged as positive in 67 patients (64.4%) and negative in the remaining 37 patients (35.6%). The IGFBP7 downregulation correlated significantly with poor postoperative prognosis, and IGFBP7 status was identified as an independent significant prognostic factor. Our results indicated that IGFBP7 expression correlated significantly with the malignant potential in HCC cells, suggesting that the expression could be a useful prognostic marker for HCC.
๐ SIMILAR VOLUMES
To determine the role of retinoblastoma (Rb) gene alteration in hepatocarcinogenesis, we examined Rb protein expression immuno-histochemically in a series of surgically resected specimens including non-cancerous liver tissues with cirrhosis or chronic hepatitis, large regenerative nodules, pre-cance
## Abstract Tumorigenesis of head and neck squamous cell carcinomas (HNSCC) is associated with various genetic changes such as loss of heterozygosity (LOH) on human chromosome 18q21. This chromosomal region maps a gene cluster coding for a family of intracellular serine protease inhibitors (serpins
Human hepatocellular carcinomas (HCC) frequently show loss of heterozygosity at loci on the short arm of chromosome 8. To define a region on 8p commonly deleted in HCC, we used 20 restriction fragment length polymorphism markers t o carry out detailed deletion mapping in 142 HCC. Of the I24 informat
Reduced expression of the cyclin-dependent kinase inhibitor p27 has previously been correlated with fatal clinical outcome in some tumors, including gastric, breast, and prostate cancers. For hepatocellular carcinoma, the findings are equivocal. In situ hybridization and immunohistochemistry were pe